PSUFU Summary Assessment reports
- Abciximab
Date of publication: 15/05/2019
- Atorvastatin
DE/H/PSUFU/00010347/201710/A
Date of publication: 18/12/2018
DE/H/PSUFU/00010347/201710/B
Date of publication: 12/03/2019
- Bupropion
Date of publication: 06/04/2020
- Carbetocin
Date of publication: 10/04/2019
- Dinoprostone
Date of publication: 12/05/2021
- Fentanyl (transmucosal route of administration)
Date of publication: 02/12/2021
- Flecainide
Date of publication: 02/10/2018
- Fluoxetine
Date of publication: 03/10/2018
- Hydroxychloroquine
Date of publication: 01/03/2023
- Irinotecan
Date of publication: 28/10/2021
- Levonorgestrel
DE/H/PSUFU/00001856/201712 (Part I)
Date of publication: 11/04/2019DE/H/PSUFU/00001856/201712 (Part II)
Date of publication: 11/04/2019
DE/H/PSUFU/00001856/201905
Date of publication: 18/12/2020
- Methotrexate
Date of pulication: 05/01/2023
- Methotrexate (for non-oncology indication(s))
Date of publication: 02/12/2021
- Minocycline
Date of publication: 30/10/2018
- Parotexine
Date of publication: 18/12/2018
- Phenobarbital
Date of publication: 12/05/2021
- Phenylephrine hydrochloride/tropicamide
Date of publication: 12/02/2019
- Rosuvastatin
Date of publication: 12/02/2019
- Testosterone (all formulations apart from topical use)
Date of publication: 12/04/2023
- Testosterone (topical use)
Date of publication 12/04/2023
- Tramadol
Date of publication: 10/04/2019
- Valaciclovir
Date of publication: 14/02/2020
Outcome of PSUSA follow-up via variation
- Bupropion
Date of publication: 17/12/2020
- Gabapentin
Date of publication: 31/03/2022
- Ifosfamide
Date of publication: 12/04/2023
- Iodixanol
NO/H/xxxx/WS/052
Date of publication: 03/08/2022
NO/H/xxxx/WS/056
Date of publication: 04/08/2022
- Iohexol
Date of publication: 25/10/2022
- Iomeprol
Date of publication: 03/08/2022
- Iopromide
NO/H/xxxx/WS/049
Date of publication: 03/08/2022
NO/H/xxxx/WS/055
Date of publication 25/10/2022
- Levonorgestrel intra-uterine devices (LNG-IUDs)
Date of publication: 03/05/2023